ROIV is trading at $33.83, up 5.0% versus the comparison close of $32.21 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 ROIV extends move to 5.0% up
Roivant Sciences Ltd
Related News
ROIV
Roivant Announces FDA Approval and Immediate Launch of LISRAYAâ„¢ for Dermatomyositis
ROIV
🔴 Roivant Sciences is trading 4.07% down today
ROIV
Roivant Announces FDA Approval for LISRAYAâ„¢, a New Dermatomyositis Treatment
ROIV
Roivant Secures FDA Approval for First Targeted Dermatomyositis Therapy
ROIV